Company
Alchemia
- Business model
- B2B
- Headquarters
- Australia
Claim, correct or request removal
Record updated 28 September 2026
About
Alchemia Limited is an Australian biotechnology company listed on the ASX with expertise in carbohydrate chemistry, which it has applied to the discovery and development of human therapeutic products. Alchemia’s first product, synthetic heparin (fondaparinux), was approved by the US FDA in 2011 and is marketed in the US under a partnership with Dr Reddy’s ...
Loading relationship preview